Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
February 14 2025 - 12:40PM
Edgar (US Regulatory)
EXHIBIT 99.1
AGREEMENT REGARDING JOINT FILING
OF STATEMENT ON SCHEDULE 13D OR 13G
The undersigned agree to file jointly with
the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D, Schedule 13G or forms 3, 4 or 5
(and any amendments or supplements thereto) required under section 13(d) or 16(a) of the Securities Exchange Act of 1934, as amended,
in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and
appoint Logos Global Management LP, a Delaware limited partnership, as their true and lawful agent and attorney-in-fact, with full power
and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other
person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Act, in
connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise of the foregoing
power, as fully as the undersigned might or could do if personally present.
Dated: February 14, 2025
|
/s/ Arsani William
Arsani William
|
|
Logos Global Management LP
By: /s/ Arsani William
Arsani William, Managing Partner |
Logos Global Master Fund LP
By Logos GP LLC, its General Partner
By: /s Arsani William
Arsani William, Managing Member
|
|
Logos Global Management GP LLC
By: /s/ Arsani William
Arsani William, Managing Member
|
Logos GP LLC
By: /s/ Arsani William
Arsani William, Managing Member
|
NextCure (NASDAQ:NXTC)
Historical Stock Chart
From Feb 2025 to Mar 2025
NextCure (NASDAQ:NXTC)
Historical Stock Chart
From Mar 2024 to Mar 2025
